Paris Attacks Prompt Isis Pharmaceuticals to Mull a Name Change
- Drugmaker says 26-year-old moniker may have become distraction
- Paris attacks were personal; `It really weighed heavily'
This article is for subscribers only.
The terrorist attacks in Paris may have finally spurred a brand change for Isis Pharmaceuticals Inc., a drugmaker that until now has steadfastly held on to its name even as the militant group rose in prominence in the Middle East.
"We want the story to be about the medicines that we’re creating, and not about our name," D. Wade Walke, a spokesman for the drugmaker, said in an interview on Wednesday. "If it looks like it’s come to that point, and it may have -- that it’s become too much of a distraction away from our core mission, and our focus -- then it’s time for a change."